In year one of the multi-year deal, a minimum order volume of 20,000 units with an estimated value of at least $1.65 million will be supplied to Onix, which would increase in years two though seven to at least 50,000 units, worth $4.1 million per year, MGC Pharma said, noting that the deal may be renewed for an extra five-year term by mutual agreement.
The ASX junior said the amended deal, along with its current level of monthly sales in Australia, is expected to deliver the company break-even cashflow at the start of year two of the agreement. Positive EBITDA is forecast for the start of 202
- Forums
- ASX - By Stock
- RGT
- Ann: March Quarterly Activity and Cashflow Report
Ann: March Quarterly Activity and Cashflow Report, page-2
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
29.0¢ |
Change
-0.025(7.94%) |
Mkt cap ! $13.13M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 29.0¢ | $688 | 2.372K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1033 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1033 | 0.290 |
1 | 2500 | 0.280 |
1 | 9600 | 0.275 |
1 | 10000 | 0.270 |
1 | 4000 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 50000 | 1 |
0.315 | 2825 | 2 |
0.335 | 8000 | 1 |
0.340 | 44885 | 3 |
0.370 | 1056 | 1 |
Last trade - 11.01am 03/07/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online